{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:45:33Z","timestamp":1793850333935,"version":"4.6.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Potential biomarkers for neuropsychiatric disorders are cerebrospinal fluid (CSF) monoamines and their corresponding precursors and metabolites. During CSF sampling, CSF flows towards the lumbar sampling site from more cranial regions. To compare the results of studies in which different CSF volumes were acquired, it is important to know if ventricular-lumbar concentration gradients exist. This has only been addressed for a few biogenic amines, and almost exclusively in neurologically unwell patients due to the burden of a lumbar puncture (necessary to obtain CSF). The aim of our study was to determine if concentration gradients exist for routinely measured CSF constituents and biogenic amines in neurologically healthy patients. We applied a novel ultrasensitive liquid chromatography mass spectrometry (LC\u2013MS\/MS) method for the simultaneous quantification of multiple monoamines, precursors and metabolites in CSF and plasma.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>CSF and blood samples were collected from twenty neurologically healthy patients undergoing spinal anaesthesia. Ten mL of lumbar CSF was collected in five consecutive two mL fractions. We determined leucocyte and erythrocyte counts, glucose, albumin and protein concentrations and quantified monoamines, precursors and metabolites on each of the fractions using LC\u2013MS\/MS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In twenty patients (60% male; median age: 46\u00a0years), dopamine, DOPAC, 3-MT, HVA, noradrenaline, normetanephrine and 5-HIAA concentrations increased from the first to the last CSF fraction (all p\u2009&lt;\u20090.001). CSF adrenaline concentrations were below the detection limit, whereas serotonin measurements were regarded as unreliable. Albumin and total protein levels decreased significantly across CSF fractions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>A ventricular-lumbar CSF concentration gradient existed for most of the investigated analytes. This is a novel finding for dopamine, noradrenaline, 3-MT and normetanephrine. These results contribute to the understanding of the neurobiology and underline the importance of standardized procedures for CSF handling to allow comparisons between studies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12987-023-00413-8","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T12:02:49Z","timestamp":1676289769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Concentration gradients of monoamines, their precursors and metabolites in serial lumbar cerebrospinal fluid of neurologically healthy patients determined with a novel LC\u2013MS\/MS technique"],"prefix":"10.1186","volume":"20","author":[{"given":"Celien","family":"Tigchelaar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willemien D.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawal D.","family":"Atmosoerodjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaas J.","family":"Wardenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido P.","family":"Kema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony R.","family":"Absalom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"van Faassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,13]]},"reference":[{"issue":"2","key":"413_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-510X(94)90298-4","volume":"122","author":"H Reiber","year":"1994","unstructured":"Reiber H. Flow rate of cerebrospinal fluid (CSF)\u2013a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci. 1994;122(2):189\u2013203.","journal-title":"J Neurol Sci"},{"key":"413_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/B978-0-12-804279-3.00002-2","volume":"146","author":"H Tumani","year":"2017","unstructured":"Tumani H, Huss A, Bachhuber F. The cerebrospinal fluid and barriers - anatomic and physiologic considerations. Handb Clin Neurol. 2017;146:21\u201332.","journal-title":"Handb Clin Neurol"},{"issue":"6","key":"413_CR3","first-page":"1103","volume":"68","author":"DA Seehusen","year":"2003","unstructured":"Seehusen DA, Reeves MM, Fomin DA. Cerebrospinal fluid analysis. Am Fam Physician. 2003;68(6):1103\u20138.","journal-title":"Am Fam Physician"},{"issue":"2","key":"413_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/PL00020042","volume":"218","author":"G Schliep","year":"1978","unstructured":"Schliep G, Felgenhauer K. Serum-CSF protein gradients, the blood-GSF barrier and the local immune response. J Neurol. 1978;218(2):77\u201396.","journal-title":"J Neurol"},{"key":"413_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2016.03.010","volume":"60","author":"A Varatharaj","year":"2017","unstructured":"Varatharaj A, Galea I. The blood-brain barrier in systemic inflammation. Brain Behav Immun. 2017;60:1\u201312.","journal-title":"Brain Behav Immun"},{"issue":"6","key":"413_CR6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.21037\/atm-20-4498","volume":"9","author":"C Tigchelaar","year":"2021","unstructured":"Tigchelaar C, Atmosoerodjo SD, van Faassen M, Wardenaar KJ, De Deyn PP, Schoevers RA, et al. The Anaesthetic Biobank of Cerebrospinal fluid: a unique repository for neuroscientific biomarker research. Ann Transl Med. 2021;9(6):455.","journal-title":"Ann Transl Med"},{"key":"413_CR7","doi-asserted-by":"publisher","first-page":"737217","DOI":"10.3389\/fnhum.2021.737217","volume":"15","author":"TO Wichmann","year":"2021","unstructured":"Wichmann TO, Damkier HH, Pedersen M. A brief overview of the cerebrospinal fluid system and its implications for brain and spinal cord diseases. Front Hum Neurosci. 2021;15:737217.","journal-title":"Front Hum Neurosci"},{"issue":"8","key":"413_CR8","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S1474-4422(11)70141-7","volume":"10","author":"MA Kurian","year":"2011","unstructured":"Kurian MA, Gissen P, Smith M, Heales S Jr, Clayton PT. The monoamine neurotransmitter disorders: an expanding range of neurological syndromes. Lancet Neurol. 2011;10(8):721\u201333.","journal-title":"Lancet Neurol"},{"issue":"10","key":"413_CR9","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nrneurol.2015.172","volume":"11","author":"J Ng","year":"2015","unstructured":"Ng J, Papandreou A, Heales SJ, Kurian MA. Monoamine neurotransmitter disorders\u2013clinical advances and future perspectives. Nat Rev Neurol. 2015;11(10):567\u201384.","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"413_CR10","doi-asserted-by":"publisher","first-page":"e947","DOI":"10.4088\/JCP.16m11144","volume":"78","author":"HS Yoon","year":"2017","unstructured":"Yoon HS, Hattori K, Ogawa S, Sasayama D, Ota M, Teraishi T, et al. Relationships of cerebrospinal fluid monoamine metabolite levels with clinical variables in major depressive disorder. J Clin Psychiatry. 2017;78(8):e947\u201356.","journal-title":"J Clin Psychiatry"},{"key":"413_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jad.2018.07.031","volume":"240","author":"J Pech","year":"2018","unstructured":"Pech J, Forman J, Kessing LV, Knorr U. Poor evidence for putative abnormalities in cerebrospinal fluid neurotransmitters in patients with depression versus healthy non-psychiatric individuals: a systematic review and meta-analyses of 23 studies. J Affect Disord. 2018;240:6\u201316.","journal-title":"J Affect Disord"},{"key":"413_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jpsychires.2018.08.028","volume":"105","author":"S Ogawa","year":"2018","unstructured":"Ogawa S, Tsuchimine S, Kunugi H. Cerebrospinal fluid monoamine metabolite concentrations in depressive disorder: a meta-analysis of historic evidence. J Psychiatr Res. 2018;105:137\u201346.","journal-title":"J Psychiatr Res"},{"issue":"2","key":"413_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1055\/s-2007-979587","volume":"28","author":"D Lester","year":"1995","unstructured":"Lester D. The concentration of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals: a meta-analysis. Pharmacopsychiatry. 1995;28(2):45\u201350.","journal-title":"Pharmacopsychiatry"},{"key":"413_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jpsychires.2021.01.045","volume":"136","author":"N Hoertel","year":"2021","unstructured":"Hoertel N, Cipel H, Blanco C, Oquendo MA, Ellul P, Leaune E, et al. Cerebrospinal fluid levels of monoamines among suicide attempters: a systematic review and random-effects meta-analysis. J Psychiatr Res. 2021;136:224\u201335.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"413_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/ane.12590","volume":"135","author":"AD Andersen","year":"2017","unstructured":"Andersen AD, Binzer M, Stenager E, Gramsbergen JB. Cerebrospinal fluid biomarkers for Parkinson\u2019s disease\u2014a systematic review. Acta Neurol Scand. 2017;135(1):34\u201356.","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"413_CR16","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s10545-018-0224-x","volume":"41","author":"M Batllori","year":"2018","unstructured":"Batllori M, Molero-Luis M, Ormazabal A, Montero R, Sierra C, Ribes A, et al. Cerebrospinal fluid monoamines, pterins, and folate in patients with mitochondrial diseases: systematic review and hospital experience. J Inherit Metab Dis. 2018;41(6):1147\u201358.","journal-title":"J Inherit Metab Dis"},{"issue":"7","key":"413_CR17","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.euroneuro.2018.04.002","volume":"28","author":"U Knorr","year":"2018","unstructured":"Knorr U, Simonsen AH, Zetterberg H, Blennow K, Hasselbalch SG, Kessing LV. Biomarkers in cerebrospinal fluid of patients with bipolar disorder versus healthy individuals: a systematic review. Eur Neuropsychopharmacol. 2018;28(7):783\u201394.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"413_CR18","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/s41380-019-0437-x","volume":"26","author":"HIL Jacobs","year":"2021","unstructured":"Jacobs HIL, Riphagen JM, Ramakers I, Verhey FRJ. Alzheimer\u2019s disease pathology: pathways between central norepinephrine activity, memory, and neuropsychiatric symptoms. Mol Psychiatry. 2021;26(3):897\u2013906.","journal-title":"Mol Psychiatry"},{"key":"413_CR19","doi-asserted-by":"publisher","first-page":"116886","DOI":"10.1016\/j.jns.2020.116886","volume":"415","author":"A Chaudhry","year":"2020","unstructured":"Chaudhry A, Houlden H, Rizig M. Novel fluid biomarkers to differentiate frontotemporal dementia and dementia with Lewy bodies from Alzheimer\u2019s disease: a systematic review. J Neurol Sci. 2020;415:116886.","journal-title":"J Neurol Sci"},{"issue":"1","key":"413_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1055\/s-0038-1673630","volume":"50","author":"H Brennenstuhl","year":"2019","unstructured":"Brennenstuhl H, Jung-Klawitter S, Assmann B, Opladen T. Inherited disorders of neurotransmitters: classification and practical approaches for diagnosis and treatment. Neuropediatrics. 2019;50(1):2\u201314.","journal-title":"Neuropediatrics"},{"issue":"2","key":"413_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0009-8981(01)00573-3","volume":"310","author":"H Reiber","year":"2001","unstructured":"Reiber H. Dynamics of brain-derived proteins in cerebrospinal fluid. Clin Chim Acta. 2001;310(2):173\u201386.","journal-title":"Clin Chim Acta"},{"issue":"22","key":"413_CR22","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","volume":"73","author":"CE Teunissen","year":"2009","unstructured":"Teunissen CE, Petzold A, Bennett JL, Berven FS, Brundin L, Comabella M, et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology. 2009;73(22):1914\u201322.","journal-title":"Neurology"},{"issue":"3\u20134","key":"413_CR23","first-page":"79","volume":"21","author":"H Reiber","year":"2003","unstructured":"Reiber H. Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics. Restor Neurol Neurosci. 2003;21(3\u20134):79\u201396.","journal-title":"Restor Neurol Neurosci"},{"issue":"8","key":"413_CR24","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1212\/WNL.32.8.893","volume":"32","author":"GP Rice","year":"1982","unstructured":"Rice GP, Armstrong H, Ebers GC. Variation in immunoglobulin G and albumin concentrations during lumbar CSF removal: a reappraisal. Neurology. 1982;32(8):893\u20134.","journal-title":"Neurology"},{"issue":"2","key":"413_CR25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000116918","volume":"33","author":"K Blennow","year":"1993","unstructured":"Blennow K, Fredman P, Wallin A, Gottfries CG, Langstrom G, Svennerholm L. Protein analyses in cerebrospinal fluid. I. Influence of concentration gradients for proteins on cerebrospinal fluid\/serum albumin ratio. Eur Neurol. 1993;33(2):126\u20138.","journal-title":"Eur Neurol"},{"issue":"1","key":"413_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13195-019-0517-9","volume":"11","author":"S Janelidze","year":"2019","unstructured":"Janelidze S, Stomrud E, Brix B, Hansson O. Towards a unified protocol for handling of CSF before beta-amyloid measurements. Alzheimers Res Ther. 2019;11(1):63.","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"413_CR27","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3233\/JAD-132708","volume":"41","author":"S Brandner","year":"2014","unstructured":"Brandner S, Thaler C, Lelental N, Buchfelder M, Kleindienst A, Maler JM, et al. Ventricular and lumbar cerebrospinal fluid concentrations of Alzheimer\u2019s disease biomarkers in patients with normal pressure hydrocephalus and posttraumatic hydrocephalus. J Alzheimers Dis. 2014;41(4):1057\u201362.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"413_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/BF02260910","volume":"5","author":"K Blennow","year":"1993","unstructured":"Blennow K, Wallin A, Gottfries CG, Mansson JE, Svennerholm L. Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid. J Neural Transm Park Dis Dement Sect. 1993;5(1):5\u201315.","journal-title":"J Neural Transm Park Dis Dement Sect"},{"issue":"3","key":"413_CR29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0022-3956(96)00007-6","volume":"30","author":"T Eklundh","year":"1996","unstructured":"Eklundh T, Eriksson M, Sjoberg S, Nordin C. Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects. J Psychiatr Res. 1996;30(3):201\u20138.","journal-title":"J Psychiatr Res"},{"issue":"2","key":"413_CR30","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1600-0404.1975.tb05767.x","volume":"52","author":"B Johansson","year":"1975","unstructured":"Johansson B, Roos BE. Concentrations of monoamine metabolites in human lumbar and cisternal cerebrospinal fluid. Acta Neurol Scand. 1975;52(2):137\u201344.","journal-title":"Acta Neurol Scand"},{"issue":"9","key":"413_CR31","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1136\/jnnp.57.9.1026","volume":"57","author":"J Malm","year":"1994","unstructured":"Malm J, Kristensen B, Ekstedt J, Wester P. CSF concentration gradients of monoamine metabolites in patients with hydrocephalus. J Neurol Neurosurg Psychiatry. 1994;57(9):1026\u201333.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"413_CR32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0022-3956(94)00048-V","volume":"29","author":"C Nordin","year":"1995","unstructured":"Nordin C, Eklundh T, Fernstrom V, Swedin A, Zachau AC. Gradients of CSF monoamine metabolites: a comparison between male and female volunteers. J Psychiatr Res. 1995;29(2):133\u201340.","journal-title":"J Psychiatr Res"},{"issue":"7","key":"413_CR33","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/jnnp.38.7.666","volume":"38","author":"R Sjostrom","year":"1975","unstructured":"Sjostrom R, Ekstedt J, Anggard E. Concentration gradients of monoamine metabolites in human cerebrospinal fluid. J Neurol Neurosurg Psychiatry. 1975;38(7):666\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"413_CR34","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jneumeth.2010.06.017","volume":"191","author":"AH Simonsen","year":"2010","unstructured":"Simonsen AH, Bech S, Laursen I, Salvesen L, Winge K, Waldemar G, et al. Proteomic investigations of the ventriculo-lumbar gradient in human CSF. J Neurosci Methods. 2010;191(2):244\u20138.","journal-title":"J Neurosci Methods"},{"issue":"13","key":"413_CR35","doi-asserted-by":"publisher","first-page":"9072","DOI":"10.1021\/acs.analchem.0c01263","volume":"92","author":"M van Faassen","year":"2020","unstructured":"van Faassen M, Bischoff R, Eijkelenkamp K, de Jong WHA, van der Ley CP, Kema IP. In matrix derivatization combined with LC\u2013MS\/MS results in ultrasensitive quantification of plasma free metanephrines and catecholamines. Anal Chem. 2020;92(13):9072\u20138.","journal-title":"Anal Chem"},{"issue":"11","key":"413_CR36","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1373\/clinchem.2019.305359","volume":"65","author":"M van Faassen","year":"2019","unstructured":"van Faassen M, Bouma G, de Hosson LD, Peters MAM, Kats-Ugurlu G, de Vries EGE, et al. Quantitative profiling of platelet-rich plasma indole markers by direct-matrix derivatization combined with LC\u2013MS\/MS in patients with neuroendocrine tumors. Clin Chem. 2019;65(11):1388\u201396.","journal-title":"Clin Chem"},{"issue":"1\u20132","key":"413_CR37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.chroma.2007.01.096","volume":"1145","author":"QL Ford","year":"2007","unstructured":"Ford QL, Burns JM, Ferry JL. Aqueous in situ derivatization of carboxylic acids by an ionic carbodiimide and 2,2,2-trifluoroethylamine for electron-capture detection. J Chromatogr A. 2007;1145(1\u20132):241\u20135.","journal-title":"J Chromatogr A"},{"key":"413_CR38","unstructured":"American Society of Anesthesiologists (December 13, 2020). ASA Physical Status Classification System. https:\/\/www.asahq.org\/standards-and-guidelines\/asa-physical-status-classification-system. Accessed 14 June 2021."},{"key":"413_CR39","first-page":"287","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988. p. 287.","edition":"2"},{"issue":"2","key":"413_CR40","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175\u201391.","journal-title":"Behav Res Methods"},{"issue":"10","key":"413_CR41","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/syn.21761","volume":"68","author":"M Tiger","year":"2014","unstructured":"Tiger M, Svenningsson P, Nord M, Jabre S, Halldin C, Lundberg J. No correlation between serotonin and its metabolite 5-HIAA in the cerebrospinal fluid and [(11) C]AZ10419369 binding measured with PET in healthy volunteers. Synapse. 2014;68(10):480\u20133.","journal-title":"Synapse"},{"issue":"3","key":"413_CR42","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1161\/01.HYP.1.3.255","volume":"1","author":"I Eide","year":"1979","unstructured":"Eide I, Kolloch R, De Quattro V, Miano L, Dugger R, Van der Meulen J. Raised cerebrospinal fluid norepinephrine in some patients with primary hypertension. Hypertension. 1979;1(3):255\u201360.","journal-title":"Hypertension"},{"issue":"4","key":"413_CR43","first-page":"1201","volume":"18","author":"J Glowinski","year":"1966","unstructured":"Glowinski J, Baldessarini RJ. Metabolism of norepinephrine in the central nervous system. Pharmacol Rev. 1966;18(4):1201\u201338.","journal-title":"Pharmacol Rev"},{"issue":"3","key":"413_CR44","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.1471-4159.1977.tb10444.x","volume":"28","author":"MG Ziegler","year":"1977","unstructured":"Ziegler MG, Lake CR, Wood JH, Brooks BR, Ebert MH. Relationship between norepinephrine in blood and cerebrospinal fluid in the presence of a blood-cerebrospinal fluid barrier for norepinephrine. J Neurochem. 1977;28(3):677\u20139.","journal-title":"J Neurochem"},{"key":"413_CR45","first-page":"57","volume":"39","author":"IJ Kopin","year":"1984","unstructured":"Kopin IJ, Blombery P, Ebert MH, Gordon EK, Jimerson DC, Markey SP, et al. Disposition and metabolism of MHPG-CD3 in humans: plasma MHPG as the principal pathway of norepinephrine metabolism and as an important determinant of CSF levels of MHPG. Adv Biochem Psychopharmacol. 1984;39:57\u201368.","journal-title":"Adv Biochem Psychopharmacol"},{"issue":"3","key":"413_CR46","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0009-8981(84)90069-X","volume":"143","author":"RA Wevers","year":"1984","unstructured":"Wevers RA, Jansen PH, van Woerkom LM, Doesburg WH, Hommes OR. The significance of total creatine kinase activity and isozyme determinations in cerebrospinal fluid of neurological patients. Clin Chim Acta. 1984;143(3):193\u2013201.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"413_CR47","doi-asserted-by":"publisher","first-page":"e90429","DOI":"10.1371\/journal.pone.0090429","volume":"9","author":"E Aasebo","year":"2014","unstructured":"Aasebo E, Opsahl JA, Bjorlykke Y, Myhr KM, Kroksveen AC, Berven FS. Effects of blood contamination and the rostro-caudal gradient on the human cerebrospinal fluid proteome. PLoS ONE. 2014;9(3):e90429.","journal-title":"PLoS ONE"},{"key":"413_CR48","volume-title":"Miller\u2019s Anesthesia","author":"RD Miller","year":"2014","unstructured":"Miller RD, Eriksson LI, Fleisher LA, Wiener-Kronish JP, Cohen NH, Young WL. Miller\u2019s Anesthesia. 8th ed. Philadelphia: Elsevier; 2014.","edition":"8"},{"issue":"1","key":"413_CR49","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/19418744211008018","volume":"12","author":"B Kakadia","year":"2022","unstructured":"Kakadia B, Badger C, Zaher M, Kavi T. Comparison of lumbar and ventricular cerebrospinal fluid for diagnosis and monitoring of meningitis. Neurohospitalist. 2022;12(1):151\u20134.","journal-title":"Neurohospitalist"},{"issue":"7","key":"413_CR50","first-page":"e9315","volume":"12","author":"S Podkovik","year":"2020","unstructured":"Podkovik S, Kashyap S, Wiginton J, Kang C, Mo K, Goodrich M, et al. Comparison of ventricular and lumbar cerebrospinal fluid composition. Cureus. 2020;12(7):e9315.","journal-title":"Cureus"},{"issue":"4","key":"413_CR51","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/j.1471-4159.1990.tb01942.x","volume":"54","author":"P Wester","year":"1990","unstructured":"Wester P, Bergstrom U, Eriksson A, Gezelius C, Hardy J, Winblad B. Ventricular cerebrospinal fluid monoamine transmitter and metabolite concentrations reflect human brain neurochemistry in autopsy cases. J Neurochem. 1990;54(4):1148\u201356.","journal-title":"J Neurochem"},{"issue":"7","key":"413_CR52","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1515\/CCLM.2004.137","volume":"42","author":"JL Dhondt","year":"2004","unstructured":"Dhondt JL. Difficulties in establishing reference intervals for special fluids: the example of 5-hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid. Clin Chem Lab Med. 2004;42(7):833\u201341.","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"413_CR53","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0924-977X(93)90295-W","volume":"3","author":"K Blennow","year":"1993","unstructured":"Blennow K, Wallin A, Gottfries CG, Karlsson I, Mansson JE, Skoog I, et al. Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18\u201388 years of age. Eur Neuropsychopharmacol. 1993;3(1):55\u201361.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"413_CR54","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0022-3956(95)00038-0","volume":"30","author":"C Nordin","year":"1996","unstructured":"Nordin C, Lindstrom L, Wieselgren IM. Acid monoamine metabolites in the CSF of healthy controls punctured without preceding strict bedrest: a retrospective study. J Psychiatr Res. 1996;30(2):127\u201333.","journal-title":"J Psychiatr Res"},{"issue":"1\u20132","key":"413_CR55","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/BF01249114","volume":"84","author":"P Hartikainen","year":"1991","unstructured":"Hartikainen P, Soininen H, Reinikainen KJ, Sirvio J, Soikkeli R, Riekkinen PJ. Neurotransmitter markers in the cerebrospinal fluid of normal subjects. Effects of aging and other confounding factors. J Neural Transm Gen Sect. 1991;84(1\u20132):103\u201317.","journal-title":"J Neural Transm Gen Sect"},{"issue":"6","key":"413_CR56","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/0022-3956(94)90041-8","volume":"28","author":"T Eklundh","year":"1994","unstructured":"Eklundh T, Fernstrom V, Nordin C. Influence of tapping-time and atmospheric pressure on concentrations of monoamine metabolites in the cerebrospinal fluid: a prospective study in female volunteers. J Psychiatr Res. 1994;28(6):511\u20137.","journal-title":"J Psychiatr Res"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-023-00413-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-023-00413-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-023-00413-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:05:56Z","timestamp":1676333156000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-023-00413-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,13]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["413"],"URL":"https:\/\/doi.org\/10.1186\/s12987-023-00413-8","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,13]]},"assertion":[{"value":"28 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethical Committee of the University Medical Center Groningen, The Netherlands (registration number 2016-174) and it conforms to the provisions of the Helsinki Declaration as revised in 2013. All participants signed an informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}